NS-1: a novel partial peroxisome proliferator-activated receptor Î³ agonist to improve insulin sensitivity and metabolic profile.

Chaudhary, Sumit; Dube, Aakanksha; Kothari, Vishal; Sachan, Narsingh; Upasani, Chandrashekhar Devidas

Chaudhary, Sumit; Dube, Aakanksha; Kothari, Vishal; Sachan, Narsingh; Upasani, Chandrashekhar Devidas.

Affiliation

Chaudhary S; Department of Pharmacology, Faculty of pharmacy, Shri Neminath Jain Bramhacharyashram's Shriman Sureshdada Jain college of pharmacy Jain gurukul, Chandwad, Nashik, India.

Eur J Pharmacol ; 684(1-3): 154-60, 2012 Jun 05.

Article in En | MEDLINE | ID: mdl-22484334

Subject(s)

Insulin Resistance; Metabolome/drug effects; PPAR gamma/agonists; Thiazolidines/pharmacology; Adipocytes/cytology; Adipocytes/drug effects; Adipogenesis/drug effects; Animals; Body Weight/drug effects; Glucose Tolerance Test; Male; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Pioglitazone; Thiazolidinediones/pharmacology; Thiazolidines/pharmacokinetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / PPAR gamma / Thiazolidines / Metabolome Type of study: Diagnostic_studies Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2012 Document type: Article Affiliation country: India Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google